Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer
The purpose of this study is to evaluate the efficacy and the safety of paclitaxel given weekly in patients with advanced or recurrent breast cancer
Inclusion Criteria:
Exclusion Criteria: